Zühlke Ventures
Corporate VCZurich · Pre-Seed–Series A · 2 people tracked
Investment thesis
Zühlke Ventures invests exclusively in early-stage HealthTech startups, aiming to recognize potential early, take minority stakes, and support portfolio companies over a 5-8 year horizon. It focuses primarily on Switzerland and Europe, with complementary interests in the US. Beyond capital, it offers access to Zühlke Group's management and technology know-how through a cooperative partnership model. Initial investments range from CHF 150k to 250k per startup.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from public directories
What they invest in
from 12 of 19 portfolio companiesMedical Devices ×11Healthtech ×8Digital Health ×6AI & Machine Learning ×2Biotech ×2Deep Tech ×2Cybersecurity ×1Enterprise Software ×1
HQs:Switzerland×7United States×5Germany×1
Investments · 19 tracked
founders shown can be your intro pathBy year:2020 · 12019 · 12 dated
HealthtechMedical DevicesLos Gatos, US
Richard Ginn(Chief Technology Officer)Kevin Williamson(Chief Financial Officer)Steven Foster(Chief Executive Officer and President)James Huie(Executive Officer)Steven Van Dick(Executive Officer)Kal Mentak(Director)
Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams.
HealthtechMedical DevicesRoboticsLausanne, CH
Boston, US
Rathi Srinivas(Executive Officer, Director)Madhavi Gavini(Executive Officer, Director)
BoardSanto Politi(Director)
DSwiss (operating as SecureSafe) builds Swiss-hosted document security software offering encrypted storage, document exchange, access control, and compliance-ready architecture for organisations handling sensitive financial, legal, and personnel data, as well as individuals.
CybersecurityEnterprise SoftwareSaaSSwitzerland, CH
Andreas(CEO)Giacomo(CTO)Veselina(VP Product)Burkhart(CFO)
evismo provides diagnostic services using sensor technology to detect cardiac arrhythmias, stress, and sleep apnea for general practitioners and specialists.
Digital HealthHealthtechMedical Devices
Flow provides a consumer-facing neurostimulation device using transcranial direct current stimulation (tDCS) for depression treatment.
Digital HealthHealthtechMedical DevicesSwitzerland, CH
Indivi is a medical technology company developing tools for precision and personalised medicine in neuroscience research and development, including Bring Your Own Device (BYOD) technology.
AI & Machine LearningDigital HealthHealthtechMedical DevicesBasel, CH
Cristina Granziera(Co-CEO)Ludwig Kappos(Co-CEO)
Koya Medical develops medical devices for lymphedema, chronic venous insufficiency, and deep vein thrombosis treatment.
HealthtechMedical DevicesOakland, US
Josh Baltzell(Director)Anand Doraiswamy(Executive Officer, Director)
BoardJan Garfinkle(Director)
Limula develops an automated, closed platform for manufacturing personalized cell and gene therapies, aiming to move production from open, manual methods to scalable automated processes.
BiotechDeep TechHardwareMedical DevicesLausanne, CH
Thomas Eaton(Founder & CEO)Yann Pierson(Founder & CTO)Caroline Boudousquié(Head of Solutions)Olivier Waridel(Head of Operations)
Exit: acquired by Broadridge in 2017.
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
PeriVision develops the VisionOne platform, combining AI, virtual reality, and cloud technology to test and understand visual function for eye conditions such as glaucoma.
AI & Machine LearningDigital HealthHealthtechMedical DevicesBasel, CH
Patrick Kessel(Co-founder, CEO & board member)Dr. Serife Kucur(Co-founder & CTO)Prof. Raphael Sznitman(Co-Founder & board member)Serife Kucur Ergunay(Co-founder, CTO & board member)Raphael Sznitman(Co-founder & board member)Kevin Gillmann(Chief Medical Officer)
Exit: acquired by Sentec in 2018.
Exits · 3
IPOs and acquisitions across the tracked portfolioTenon MedicalNASDAQ: TNONMessage Automationacq. by BroadridgeSwisstomacq. by Sentec
Portfolio news
latest coverage across their companiesAluna · apgcapitalmarkets.com · Sep 28, 2025
Frequently asked questions
- What stage does Zühlke Ventures invest at?
- Zühlke Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Zühlke Ventures's typical check size?
- Zühlke Ventures typically writes checks of $165K – $275K.
- What sectors does Zühlke Ventures focus on?
- Zühlke Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Zühlke Ventures located?
- Zühlke Ventures is headquartered in Zurich, CH.
- Does Zühlke Ventures lead rounds?
- Zühlke Ventures typically participates in rounds rather than leading them.
Media · Podcasts & interviews
from their channelAI-assisted software archaeology: turning legacy guesswork into evidence
Zühlke Group
Are leaders deploying AI faster than they can effectively govern it? With Zahra Shah
Zühlke Group
Is it possible for ‘tech for good’ to exist within a for-profit model? With Jim Fruchterman
Zühlke Group
Resilience Rewired: Inside Swissgrid's move to autonomous drone inspection
Zühlke Group
Resilienz neu gedacht: Wie Swissgrid autonome Drohneninspektionen realisiert
Zühlke Group
Is irrational AI making our decision-making worse? With Stephanie Antonian
Zühlke Group
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Future Positive Capital is an investment firm backing entrepreneurs building companies that address major global challenges and shape more sustainable, preferable futures.